L&G S Pharma Breakthrough Go UCITS 

$15.13
9
-$0.01-0.05%Friday 16:15

Statistics

Day High
15.25
Day Low
14.98
52W High
16.19
52W Low
12.38
Volume
15,955.65
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Expense Ratio

0.49%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIOT.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Invesco Pharmaceuticals
PJP
Mkt Cap0
PowerShares Dynamic Pharmaceuticals ETF, tracks a dynamic pharmaceutical index, directly competing in the pharmaceutical investment space.
State Street SPDR S&P Pharmaceuticals
XPH
Mkt Cap0
SPDR S&P Pharmaceuticals ETF, focuses on the pharmaceutical industry, similar to BIGT.LSE's focus.
iShares U.S. Pharmaceuticals
IHE
Mkt Cap0
iShares U.S. Pharmaceuticals ETF, invests in U.S. pharmaceutical companies, competing for the same investor base.
Fidelity MSCI Health Care Index
FHLC
Mkt Cap0
Fidelity MSCI Health Care Index ETF, includes pharmaceuticals within a broader healthcare sector, appealing to similar investors.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, targets biotechnology but overlaps significantly with pharmaceutical investments.
ProShares Ultra Nasdaq Biotechnology 2X Shares
BIB
Mkt Cap0
ProShares Ultra Nasdaq Biotechnology, focuses on biotechnology with implications for pharmaceuticals, competing in high-tech healthcare investment.
iShares Biotechnology
IBB
Mkt Cap0
iShares Nasdaq Biotechnology ETF, includes biotech firms that are closely related to the pharmaceutical industry.
Vanguard Health Care
VHT
Mkt Cap0
Vanguard Health Care ETF, covers a broad range of healthcare stocks including pharmaceuticals, competing for similar investment funds.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF, focuses on biotech but intersects with pharmaceutical research and development.
State Street Health Care Select Sector SPDR
XLV
Mkt Cap0
Health Care Select Sector SPDR Fund, includes pharmaceutical companies within a larger healthcare context, attracting similar types of investors.

Holdings

Regions

Sectors

About

The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.
Show More
CEO
Sara Murray
Employees
284
Country
Ireland
ISIN
IE00BF0H7608
WKN
000A2H9XR

Listings

0 Comments

Share your thoughts

FAQs

What is L&G S Pharma Breakthrough Go UCITS stock price today?▼
The current price of BIOT.LSE is $15.13 USD — it has decreased by -0.05% in the past 24 hours. Watch L&G S Pharma Breakthrough Go UCITS stock price performance more closely on the chart.
What is L&G S Pharma Breakthrough Go UCITS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange L&G S Pharma Breakthrough Go UCITS stocks are traded under the ticker BIOT.LSE.
Is L&G S Pharma Breakthrough Go UCITS stock price growing?▼
BIOT.LSE stock has risen by +3.79% compared to the previous week, the month change is a +2.7% rise, over the last year L&G S Pharma Breakthrough Go UCITS has showed a +14.02% increase.
How many employees does L&G S Pharma Breakthrough Go UCITS have?▼
As of October 31, 2026, the company has 284 employees.
In which sector is L&G S Pharma Breakthrough Go UCITS located?▼
L&G S Pharma Breakthrough Go UCITS operates in the Finance & Payments sector.
When did L&G S Pharma Breakthrough Go UCITS complete a stock split?▼
L&G S Pharma Breakthrough Go UCITS has not had any recent stock splits.
Where is L&G S Pharma Breakthrough Go UCITS headquartered?▼
L&G S Pharma Breakthrough Go UCITS is headquartered in Dublin, Ireland.